CCM
Camber Capital Management Portfolio holdings
AUM
$718M
This Quarter Return
+9.97%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$2.86B
AUM Growth
+$2.86B
(+2.7%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-6.24%
Top 10 Holdings %
Top 10 Hldgs %
66.68%
Holding
46
New
5
Increased
11
Reduced
9
Closed
8
Top Buys
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$83M |
| 2 |
Baxter International
BAX
|
$77.3M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$47M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$43M |
| 5 |
Medtronic
MDT
|
$28.8M |
Top Sells
| 1 |
Sanofi
SNY
|
$148M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$104M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$70.1M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$65.3M |
| 5 |
Dentsply Sirona
XRAY
|
$60.3M |
Sector Composition
| 1 | Healthcare | 96.89% |
| 2 | Consumer Staples | 1.45% |
| 3 | Consumer Discretionary | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Universal Health Services
UHS
$11.6B
| $285M | 7.26% | 1,870,000 -130,000 | -7% | -$19.8M |
|
2
Tenet Healthcare
THC
$16.3B
| $283M | 7.21% | 3,745,000 +95,000 | +3% | +$7.18M |
|
3
Zimmer Biomet
ZBH
$21B
| $234M | 5.97% | 1,925,000 +75,000 | +4% | +$9.13M |
|
4
Viatris
VTRS
$12.3B
| $200M | 5.11% | 18,500,000 -1,500,000 | -8% | -$16.2M |
|
|
5
Baxter International
BAX
$12.7B
| $193M | 4.93% | 5,000,000 +2,000,000 | +67% | +$77.3M |
|
|
WBA
6
DELISTED
Walgreens Boots Alliance
WBA
| $183M | 4.66% | 7,000,000 +1,800,000 | +35% | +$47M |
|
|
7
Medtronic
MDT
$119B
| $152M | 3.88% | 1,850,000 +350,000 | +23% | +$28.8M |
|
8
Myriad Genetics
MYGN
$593M
| $146M | 3.72% | 7,635,000 +1,000,000 | +15% | +$19.1M |
|
9
Globus Medical
GMED
$8.27B
| $120M | 3.06% | 2,250,000 +525,000 | +30% | +$28M |
|
10
PTC Therapeutics
PTCT
$3.92B
| $110M | 2.81% | 4,000,000 +600,000 | +18% | +$16.5M |
|
11
Brookdale Senior Living
BKD
$1.83B
| $90.2M | 2.3% | 15,500,000 -2,500,000 | -14% | -$14.6M |
|
|
12
Jazz Pharmaceuticals
JAZZ
$7.75B
| $83M | 2.12% | +675,000 | New | +$83M |
|
13
GSK
GSK
$79.9B
| $80.6M | 2.05% | 2,175,000 -675,000 | -24% | -$25M |
|
14
Select Medical
SEM
$1.61B
| $79.9M | 2.04% | 3,400,000 | – | – |
|
15
Sarepta Therapeutics
SRPT
$1.78B
| $77.1M | 1.97% | 800,000 | – | – |
|
16
Perrigo
PRGO
$3.27B
| $59.5M | 1.52% | 1,850,000 | – | – |
|
17
ZimVie
ZIMV
$532M
| $57.7M | 1.47% | 3,250,000 | – | – |
|
|
18
Ionis Pharmaceuticals
IONS
$6.79B
| $43.8M | 1.12% | 865,000 -1,385,000 | -62% | -$70.1M |
|
|
19
Ultragenyx Pharmaceutical
RARE
$2.89B
| $43M | 1.1% | +900,000 | New | +$43M |
|
20
OraSure Technologies
OSUR
$242M
| $34.9M | 0.89% | 4,250,000 | – | – |
|
21
Collegium Pharmaceutical
COLL
$1.22B
| $32.3M | 0.82% | 1,050,000 | – | – |
|
22
Herbalife
HLF
$1.01B
| $30.5M | 0.78% | 2,000,000 -850,000 | -30% | -$13M |
|
23
QuidelOrtho
QDEL
$1.95B
| $29.5M | 0.75% | 400,000 +75,000 | +23% | +$5.53M |
|
24
Peloton Interactive
PTON
$3.1B
| $27.4M | 0.7% | 4,500,000 | – | – |
|
25
Qiagen
QGEN
$10.1B
| $26.7M | 0.68% | 615,000 +215,000 | +54% | +$9.34M |
|